Brief: Zynerba Pharmaceuticals Announces Planned Retirement Of Suzanne Hanlon And Appoints Albert P. Parker As Chief Legal Officer
15/02/2022 13:09
Feb 15 (Reuters) - Zynerba Pharmaceuticals Inc ZYNE.O :
* ZYNERBA PHARMACEUTICALS ANNOUNCES PLANNED RETIREMENT OF
SUZANNE
HANLON AND APPOINTS ALBERT P. PARKER AS CHIEF LEGAL OFFICER
Source text for Eikon: ID:nGNX9GcQ4x
Further company coverage: ZYNE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zynerba Pharmaceuticals
See all newsBrief: Harmony Biosciences Completes Acquisition Of Zynerba Pharmaceuticals
Brief: Harmony Biosciences Announces Extension Of Tender Offer To Acquire Zynerba Pharmaceuticals, Inc.
Brief: Zynerba Pharmaceuticals Presents Positive Data From Phase 2 Inspire Trial
U.S. RESEARCH ROUNDUP-Easterly Government Properties, Visa, Zynerba Pharmaceuticals
Zynerba Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary